Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I

Henry T. Lynch, Stephen J. Lanspa, Thomas Smyrk, Bruce Boman, Patrice Watson, Jane Lynch

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is common, accounting for about 4-6% of the total colorectal cancer burden. It is heterogeneous and appears to be delineated into two clinical subsets, Lynch syndromes I and II. Lynch syndrome I is characterized by an autosomal dominantly inherited proclivity to early onset colonic cancer with proximal predominance and an excess of multiple primary colonic cancer. Lynch syndrome II has all of these features plus extracolonic cancer sites, the most common of which is endometrial carcinoma. The lack of premonitory physical signs or biomarkers of HNPCC makes diagnosis difficult. A careful family history, tempered by an understanding of the clinical and pathologic features of HNPCC, is the key to its assessment. This paper reviews HNPCC's natural history, its integral extracolonic cancer associations, its differential diagnosis, surveillance, and management strategies. Attention is focused upon the need for biomarker research in the interest of improving control of HNPCC.

Original languageEnglish
Pages (from-to)143-160
Number of pages18
JournalCancer Genetics and Cytogenetics
Volume53
Issue number2
DOIs
StatePublished - 1991

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Natural History
Pathology
Lynch Syndrome II
Neoplasms
Colonic Neoplasms
Biomarkers
Endometrial Neoplasms
Colorectal Neoplasms
Differential Diagnosis
Research

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I. / Lynch, Henry T.; Lanspa, Stephen J.; Smyrk, Thomas; Boman, Bruce; Watson, Patrice; Lynch, Jane.

In: Cancer Genetics and Cytogenetics, Vol. 53, No. 2, 1991, p. 143-160.

Research output: Contribution to journalArticle

@article{ee236fe38d7d4e308d50828b9cef954e,
title = "Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I",
abstract = "Hereditary nonpolyposis colorectal cancer (HNPCC) is common, accounting for about 4-6{\%} of the total colorectal cancer burden. It is heterogeneous and appears to be delineated into two clinical subsets, Lynch syndromes I and II. Lynch syndrome I is characterized by an autosomal dominantly inherited proclivity to early onset colonic cancer with proximal predominance and an excess of multiple primary colonic cancer. Lynch syndrome II has all of these features plus extracolonic cancer sites, the most common of which is endometrial carcinoma. The lack of premonitory physical signs or biomarkers of HNPCC makes diagnosis difficult. A careful family history, tempered by an understanding of the clinical and pathologic features of HNPCC, is the key to its assessment. This paper reviews HNPCC's natural history, its integral extracolonic cancer associations, its differential diagnosis, surveillance, and management strategies. Attention is focused upon the need for biomarker research in the interest of improving control of HNPCC.",
author = "Lynch, {Henry T.} and Lanspa, {Stephen J.} and Thomas Smyrk and Bruce Boman and Patrice Watson and Jane Lynch",
year = "1991",
doi = "10.1016/0165-4608(91)90093-A",
language = "English",
volume = "53",
pages = "143--160",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I

AU - Lynch, Henry T.

AU - Lanspa, Stephen J.

AU - Smyrk, Thomas

AU - Boman, Bruce

AU - Watson, Patrice

AU - Lynch, Jane

PY - 1991

Y1 - 1991

N2 - Hereditary nonpolyposis colorectal cancer (HNPCC) is common, accounting for about 4-6% of the total colorectal cancer burden. It is heterogeneous and appears to be delineated into two clinical subsets, Lynch syndromes I and II. Lynch syndrome I is characterized by an autosomal dominantly inherited proclivity to early onset colonic cancer with proximal predominance and an excess of multiple primary colonic cancer. Lynch syndrome II has all of these features plus extracolonic cancer sites, the most common of which is endometrial carcinoma. The lack of premonitory physical signs or biomarkers of HNPCC makes diagnosis difficult. A careful family history, tempered by an understanding of the clinical and pathologic features of HNPCC, is the key to its assessment. This paper reviews HNPCC's natural history, its integral extracolonic cancer associations, its differential diagnosis, surveillance, and management strategies. Attention is focused upon the need for biomarker research in the interest of improving control of HNPCC.

AB - Hereditary nonpolyposis colorectal cancer (HNPCC) is common, accounting for about 4-6% of the total colorectal cancer burden. It is heterogeneous and appears to be delineated into two clinical subsets, Lynch syndromes I and II. Lynch syndrome I is characterized by an autosomal dominantly inherited proclivity to early onset colonic cancer with proximal predominance and an excess of multiple primary colonic cancer. Lynch syndrome II has all of these features plus extracolonic cancer sites, the most common of which is endometrial carcinoma. The lack of premonitory physical signs or biomarkers of HNPCC makes diagnosis difficult. A careful family history, tempered by an understanding of the clinical and pathologic features of HNPCC, is the key to its assessment. This paper reviews HNPCC's natural history, its integral extracolonic cancer associations, its differential diagnosis, surveillance, and management strategies. Attention is focused upon the need for biomarker research in the interest of improving control of HNPCC.

UR - http://www.scopus.com/inward/record.url?scp=0025915010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025915010&partnerID=8YFLogxK

U2 - 10.1016/0165-4608(91)90093-A

DO - 10.1016/0165-4608(91)90093-A

M3 - Article

C2 - 1648437

AN - SCOPUS:0025915010

VL - 53

SP - 143

EP - 160

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -